Symptoms Control and adhErenCe Assessment During Treatment With MepolizUmab New pREfilled Devices
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Compare the Pharmacokinetics (PK) of Depemokimab When Delivered With a Safety Syringe Device (SSD) or an Autoinjector in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adults 60 Years of Age and Above
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age Inclusive
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2b Study of GSK4532990 in Adults With NASH
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Managed Access Program for Momelotinib in Myelofibrosis
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above
- Status
- COMPLETED
- Phase
- PHASE3
A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years
- Status
- COMPLETED
- Phase
- PHASE1
A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above
- Status
- COMPLETED
- Phase
- PHASE3
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1
- Status
- COMPLETED
- Phase
- PHASE2
To Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a Single Inhaler (Trelegy Ellipta) in Participants With Symptomatic COPD
- Status
- COMPLETED
- Phase
- PHASE4
Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 1b/2 Trial Evaluating Safety and Efficacy of CAPecitabine in Combination With Ni-rapaRIb in HER2-negative Advanced Breast canCEr
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
First-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV367
- Status
- COMPLETED
- Phase
- PHASE1